Effipro duo (1 - 6 kg)
ATC code
Species
Cats.
Indications
In cats, to be used against infestations with fleas alone or in association with ticks.
Against fleas:
Treatment and prevention of infestations by fleas (Ctenocephalides felis). One treatment prevents further infestations for 5 weeks.
Prevention of the multiplication of fleas by preventing flea eggs developing into adult fleas for 12 weeks after application.
The product can be used as part of a treatment strategy for the control of Flea Allergy Dermatitis (FAD) where this has been previously diagnosed by a veterinary surgeon.
Against ticks:
Treatment of infestations by ticks (Ixodes ricinus and Rhipicephalus turanicus).
One treatment provides persistent acaricidal efficacy for one week.
If ticks are present at the time of application, not all ticks may be killed within 48 hours.
Dose to be administered and administration route
Spot-on use.
Dosage:
For a cat weighing 1-6 kg apply one pipette of 0.5 ml per cat corresponding to the minimum recommended dose of 8.3 mg fipronil/kg b.w. and 10 mg pyriproxyfen/kg b.w..
|
Cat weight |
Pipette volume |
Fipronil (mg) |
Pyriproxyfen (mg) |
|
|
1-6 kg |
0.5 ml |
50 |
60 |
|
|
>6-12 kg |
1 ml |
100 |
120 |
For a cat weighing more than 6 kg a recommended dose of 1 ml should be applied, which can be achieved by applying two 0.5 ml pipettes.
Method of administration:
Remove the pipette from the overblister. Hold the pipette upright. Tap the narrow part of the pipette to ensure that the contents are within the main body of the pipette. Break the snap-off top of the spot-on pipette along the scored line.
Part the coat on the back of neck area until the skin is visible. Place the tip of the pipette on the skin and squeeze firmly several times to empty the contents evenly at one or two spots. Ensure the solution is applied to healthy skin only and avoid superficial application to the cat’s hair or run off.
Drop stop system (the product is released only by pressing the body of the pipette).
Consult your veterinary surgeon if the product fails to control the flea and tick infestation. However, in the absence of additional safety studies, do not repeat the treatment at intervals of less than 4 weeks (see section 4.10).
Adverse reactions
Transient cosmetic effects such as wet appearance or slight scaling can occur very rarely at the application site.
According to the accumulated experience on these active ingredients within spot on pharmaceutical forms, transient cutaneous reactions at the application site as squamosis (scaling of the skin), local alopecia (hair loss), pruritus (itchiness), erythema (redness of the skin), skin discolouration and general pruritus or alopecia may very rarely be observed after use. Hypersalivation, reversible neurologic symptoms as hyperesthesia (increased sensitivity to stimuli), depression and nervous symptoms may very rarely be observed. Respiratory signs or vomiting might occur in very rare cases.
The frequency of adverse reactions is defined using the following convention:
- very common (more than 1 in 10 animals treated displaying adverse reaction(s))
- common (more than 1 but less than 10 animals in 100 animals treated)
- uncommon (more than 1 but less than 10 animals in 1,000 animals treated )
- rare (more than 1 but less than 10 animals in 10,000 animals treated)
- very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
